
IDEOM stakeholders: Join us on June 17th & 18th for the IDEOM annual meeting in Washington, DC. Check your email for a link to register. We look forward to seeing you there!
IDEOM Annual Meeting 2021
November 19 - 20, 2021
The IDEOM Annual Meeting is open to all IDEOM stakeholders. If you are not an IDEOM stakeholder, please contact Amanda Pacia at amanda@dermoutcomes.org to learn more.
IDEOM at GRAPPA 2021
July 8, 2021
This meeting is intended for all IDEOM Psoriatic Disease stakeholders and all GRAPPA members. IDEOM will present an overview and PsA Musculoskeletal Symptoms Workgroup projects.
IDEOM Annual Meeting 2020
Original Meeting Rescheduled Due to Covid 19
New Date: October 23-24, 2020
2020 IDEOM Virtual Meeting Adjacent to GRAPPA: Psoriasis Musculoskeletal Symptoms Workgroup
Thursday, July 9, 2020
11:15 - 13:15 EST
2020 IDEOM Virtual Meeting Adjacent to GRAPPA: Psoriasis Musculoskeletal Symptoms Workgroup
















IDEOM Meeting at 24th World Congress of Dermatology
Sunday, June 9, 2019
Sheraton Diana Majestic Milan Hotel
Viale Piave 42 - 20129
Milan, Italy
IDEOM Meeting at 24th World Congress of Dermatology
















2019 IDEOM Annual Meeting
Friday May 17 & Saturday May 18, 2019
Location: At the BRAND NEW Hilton Washington DC National Mall
480 L'Enfant Plaza SW I Washington, DC 20024 I USA
Washington, DC
EVENT TESTIMONIAL: Read what participants had to say about this event Here
2019 IDEOM Annual Meeting













































2018 IDEOM Annual Meeting
Friday May 4 & Saturday May 5, 2018
The Mayflower Hotel
1127 Connecticut Avenue NW
Washington, DC
2018 IDEOM Annual Meeting













































2017 IDEOM Annual Meeting
Friday May 5 & Saturday May 6, 2017
The Mayflower Hotel
1127 Connecticut Avenue NW
Washington, DC
2016 IDEOM Annual Meeting
March 2, 2016
Westin Washington, DC City Center
1400 M St NW
Washington, DC 20005
The annual meeting of IDEOM was held on March 2, 2016, at the Westin Washington, DC City Center in Washington DC. After anintroduction about what IDEOM does, the meeting continued with Leah Howard, from the National Psoriasis Foundation (NPF),presenting data on how payers assess quality of treatments in psoriasis. Then, Dr. Kendall Marcus, Head of the U.S. Food and Drug Administration’s (FDA) Dermatology Division, gave a presentation on outcomes in dermatology. The rest of the morning and part of the afternoon showcased results of our most recent DELPHI exercise. We did live DELPHI exercises at this meeting and hopefully will choose our final list of domains and discuss next steps. During lunch and breaks, attendees were able to view posters containing submitted outcomes research in dermatology. Towards the latter part of the afternoon, the Hidradenitis Suppurativa (HS) working group discussed its goals and next steps. The Acne Outcomes Research Group (ACORN) presented their work and discussed how IDEOM can help them in their efforts.
2016 IDEOM Annual Meeting













